Singapore Medial Group a 'buy' as it builds IVF arm

SINGAPORE (Feb 6): RHB is maintaining its “buy” call on Singapore Medical Group (SMG) with a target price of 79 cents.

This came on the back of the group entering into a joint venture (JV) with South Korea’s CHA Medical Group to enter the Australian market by acquiring a 65% stake in City Fertility Centre (CFC), Australia’s fourth largest in vitro fertilisation (IVF) clinic group.